Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
Dale
David C
DC
D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy* / Q000628:therapy; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012307:Risk Factors; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
D003115:Colony-Stimulating Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim